Meticulous Research®– a leading global market research company published a research report titled “Antimicrobial Susceptibility Testing Market, by Product (Manual {Susceptibility Discs, Plates, MIC Strips}, Consumables, Automated), Method (Diffusion, Dilution), Application (Clinical Diagnostics), End User (Hospitals, Pharma, Institutes) – Forecast to 2028.”
Download free sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5062?utm_source=blog&utm_medium=social+&utm_campaign=product&utm_content=25-06-2024
According to this latest publication from Meticulous Research®, the Antimicrobial Susceptibility Testing Market is expected to reach $5.99 billion by 2028, at a CAGR of ~6.4% during the forecast period. Some of the major factors driving the growth of the market include the high prevalence of infectious diseases, development of automated AST products, increasing government initiatives and funding towards antimicrobial susceptibility testing programs, technological advancements towards the development of new AST methods, and the emergence of multidrug resistance in microorganisms. However, stringent government regulations are expected to hinder the growth of this market to a certain extent. Emerging markets and active R&D to develop rapid antimicrobial susceptibility testing are expected to offer significant growth opportunities for players operating in the antimicrobial susceptibility testing market.
Antimicrobial Susceptibility Testing Market: Future Outlook
Based on product, the antimicrobial susceptibility testing market is segmented into manual antimicrobial susceptibility testing products, automated antimicrobial susceptibility testing products, and consumables. In 2021, the manual antimicrobial susceptibility testing products segment is expected to account for the largest share of the antimicrobial susceptibility testing market. The growth in this market is driven by and the low cost of the manual AST products and simple handling procedures. Availability of a diverse range of consumables for manual testing and easy interpretation of tests are further propelling the growth of this segment.
Based on method, the disk diffusion segment is expected to account for the largest share of the antimicrobial susceptibility testing market in 2021. The low cost associated with performing AST testing with the disk diffusion method and developments in the disk diffusion method with the use of automated technology is primarily boosting the segment growth.
Based on application, the clinical diagnostics segment is expected to account for the largest share of the antimicrobial susceptibility testing market in 2021 due to the rising burden of antimicrobial resistance and growing awareness about the use of antimicrobial susceptibility testing methods.
The key players operating in the antimicrobial susceptibility testing market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Becton, Dickinson and Company (U.S.), Danaher Corporation (U.S.), HiMedia Laboratories Pvt. Ltd. (India), MERLIN Diagnostika GmbH (Germany), Accelerate Diagnostics, Inc. (U.S.), Alifax S.r.l. (Italy), Creative Diagnostics (U.S.), Synbiosis (U.K.), and Zhuhai DL Biotech Co., Ltd (China), among others.
Contact Us:
Meticulous Research®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research